Cariprazine: A new partial dopamine agonist with a familiar profile.

Judith D HopeNicholas A Keks

Published in: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists (2022)

prolongation are low. Cariprazine is another 'metabolically-friendly' antipsychotic for schizophrenia, with advantages for those with negative symptoms, mood symptoms or problems with adherence.

Keyphrases

bipolar disorder
sleep quality
mental health
uric acid
type diabetes
physical activity
low cost